3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
25
Burkitt Lymphoma
15
Sarcoma
14
Neoplasms
11
Lymphoma, Follicular
11
Lymphoma
11
Hodgkin Disease
10
Breast Neoplasms
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Non-Hodgkin
9
Triple Negative Breast Neoplasms
8
Ovarian Neoplasms
8
Endometrial Neoplasms
8
Lymphoma, B-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Recurrence
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm Metastasis
5
Fallopian Tube Neoplasms
5
Wilms Tumor
4
Osteosarcoma
4
Lymphoma, Mantle-Cell
4
Liposarcoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Sarcoma, Ewing
3
Neuroblastoma
3
Lymphoproliferative Disorders
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia
3
Interventions
Magnetic Resonance Spectroscopy
12
Specimen Handling
11
Cisplatin
10
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Radiotherapy, Intensity-Modulated
7
pembrolizumab
6
Carboplatin
6
Cetuximab
5
Radiation
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
Taxes
3
Radiotherapy
3
Paclitaxel
3
Docetaxel
3
ipatasertib
2
cemiplimab
2
X-Rays
2
Interviews as Topic
2
Immunoglobulin G
2
Disulfides
2
toripalimab
1
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
cabozantinib
1
atezolizumab
1
Tretinoin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
Doxorubicin
×
90 days
×
Clear all
No trials found.